BRIEF-Bharat Biotech's COVAXIN COVID-19 Vaccine Demonstrates Interim Clinical Efficacy Of 81% - Reuters

Reuters | March 3, 2021, 7:54 a.m. | Original
BRIEF-Bharat Biotech's COVAXIN COVID-19 Vaccine Demonstrates Interim Clinical Efficacy Of 81% Reuters
EU vows legal response as UK moves unilaterally on Northern Ireland - Reuters Exclusive: U.S. House Democrats urge Biden to revert to Obama-era Cuba detente - Reuters